1. Home
  2. ZVRA vs ITIC Comparison

ZVRA vs ITIC Comparison

Compare ZVRA & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$8.10

Market Cap

499.9M

Sector

Health Care

ML Signal

N/A

Logo Investors Title Company

ITIC

Investors Title Company

N/A

Current Price

$252.81

Market Cap

517.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ZVRA
ITIC
Founded
2006
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
499.9M
517.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ZVRA
ITIC
Price
$8.10
$252.81
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$21.71
N/A
AVG Volume (30 Days)
1.1M
18.9K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
6.35%
EPS Growth
N/A
25.81
EPS
0.54
19.00
Revenue
$84,388,000.00
$273,864,000.00
Revenue This Year
$333.25
N/A
Revenue Next Year
$43.70
N/A
P/E Ratio
$15.11
$13.13
Revenue Growth
244.60
13.63
52 Week Low
$6.19
$190.20
52 Week High
$13.16
$288.98

Technical Indicators

Market Signals
Indicator
ZVRA
ITIC
Relative Strength Index (RSI) 36.09 44.61
Support Level $8.05 $248.74
Resistance Level $8.58 $256.00
Average True Range (ATR) 0.34 7.38
MACD -0.00 -0.86
Stochastic Oscillator 6.63 33.03

Price Performance

Historical Comparison
ZVRA
ITIC

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About ITIC Investors Title Company

Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.

Share on Social Networks: